Matches in Wikidata for { <http://www.wikidata.org/entity/Q91013826> ?p ?o ?g. }
- Q91013826 description "2019 nî lūn-bûn" @default.
- Q91013826 description "2019年の論文" @default.
- Q91013826 description "2019年学术文章" @default.
- Q91013826 description "2019年学术文章" @default.
- Q91013826 description "2019年学术文章" @default.
- Q91013826 description "2019年学术文章" @default.
- Q91013826 description "2019年学术文章" @default.
- Q91013826 description "2019年學術文章" @default.
- Q91013826 description "2019年學術文章" @default.
- Q91013826 description "2019年學術文章" @default.
- Q91013826 description "2019年學術文章" @default.
- Q91013826 description "2019年學術文章" @default.
- Q91013826 description "2019年學術文章" @default.
- Q91013826 description "2019년 논문" @default.
- Q91013826 description "article científic" @default.
- Q91013826 description "article scientific" @default.
- Q91013826 description "article scientifique (publié 2019)" @default.
- Q91013826 description "articol științific" @default.
- Q91013826 description "articolo scientifico" @default.
- Q91013826 description "artigo científico (publicado na 2019)" @default.
- Q91013826 description "artigo científico (publicado na 2019)" @default.
- Q91013826 description "artigo científico" @default.
- Q91013826 description "artikull shkencor" @default.
- Q91013826 description "artikulong pang-agham" @default.
- Q91013826 description "artykuł naukowy" @default.
- Q91013826 description "artículo científico publicado en 2019" @default.
- Q91013826 description "artículu científicu" @default.
- Q91013826 description "bilimsel makale" @default.
- Q91013826 description "bài báo khoa học" @default.
- Q91013826 description "im November 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91013826 description "mokslinis straipsnis" @default.
- Q91013826 description "naučni članak" @default.
- Q91013826 description "scienca artikolo" @default.
- Q91013826 description "scientific article" @default.
- Q91013826 description "teaduslik artikkel" @default.
- Q91013826 description "tieteellinen artikkeli" @default.
- Q91013826 description "tudományos cikk" @default.
- Q91013826 description "vedecký článok" @default.
- Q91013826 description "vetenskaplig artikel" @default.
- Q91013826 description "videnskabelig artikel (udgivet 2019)" @default.
- Q91013826 description "vitenskapelig artikkel" @default.
- Q91013826 description "vitskapeleg artikkel" @default.
- Q91013826 description "vědecký článek" @default.
- Q91013826 description "wetenschappelijk artikel" @default.
- Q91013826 description "επιστημονικό άρθρο" @default.
- Q91013826 description "мақолаи илмӣ" @default.
- Q91013826 description "мақолаи илмӣ" @default.
- Q91013826 description "наукова стаття" @default.
- Q91013826 description "научна статия" @default.
- Q91013826 description "научная статья" @default.
- Q91013826 description "научни чланак" @default.
- Q91013826 description "научни чланак" @default.
- Q91013826 description "գիտական հոդված" @default.
- Q91013826 description "מאמר מדעי" @default.
- Q91013826 description "سائنسی مضمون" @default.
- Q91013826 description "مقالة علمية" @default.
- Q91013826 description "مقالهٔ علمی" @default.
- Q91013826 description "২০১৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q91013826 description "บทความทางวิทยาศาสตร์" @default.
- Q91013826 description "სამეცნიერო სტატია" @default.
- Q91013826 name "Idelalisib addition has neutral to beneficial effects on quality of life in bendamustine/rituximab-treated patients: results of a phase 3, randomized, controlled trial." @default.
- Q91013826 name "Idelalisib addition has neutral to beneficial effects on quality of life in bendamustine/rituximab-treated patients: results of a phase 3, randomized, controlled trial." @default.
- Q91013826 type Item @default.
- Q91013826 label "Idelalisib addition has neutral to beneficial effects on quality of life in bendamustine/rituximab-treated patients: results of a phase 3, randomized, controlled trial." @default.
- Q91013826 label "Idelalisib addition has neutral to beneficial effects on quality of life in bendamustine/rituximab-treated patients: results of a phase 3, randomized, controlled trial." @default.
- Q91013826 prefLabel "Idelalisib addition has neutral to beneficial effects on quality of life in bendamustine/rituximab-treated patients: results of a phase 3, randomized, controlled trial." @default.
- Q91013826 prefLabel "Idelalisib addition has neutral to beneficial effects on quality of life in bendamustine/rituximab-treated patients: results of a phase 3, randomized, controlled trial." @default.
- Q91013826 P1433 Q91013826-F85C4752-716D-46D7-BB37-35B10F13B982 @default.
- Q91013826 P1476 Q91013826-CD05355B-8729-4813-95AA-30007CA4DA88 @default.
- Q91013826 P2093 Q91013826-085CA113-9091-44D4-AFF7-5636BA4C7C14 @default.
- Q91013826 P2093 Q91013826-0AF7A2D8-57ED-484A-BC19-7546928875FD @default.
- Q91013826 P2093 Q91013826-214B80DC-F602-459B-BD23-0BCCD677D446 @default.
- Q91013826 P2093 Q91013826-60598B88-D81E-43F9-BFE2-B3FE692843E2 @default.
- Q91013826 P2093 Q91013826-663745EC-3BCF-41F9-BF0E-F089E7AFAE72 @default.
- Q91013826 P2093 Q91013826-9E3E0DA5-423D-4763-802E-CC5B624A696E @default.
- Q91013826 P2093 Q91013826-A30FE8DB-8C7B-4996-9DA4-50A8F1A1B2AA @default.
- Q91013826 P2093 Q91013826-DE088696-251A-4A86-A26F-C653DECF24BC @default.
- Q91013826 P2093 Q91013826-E8E69387-C7BA-4CD7-BDB3-04BEE009961E @default.
- Q91013826 P2093 Q91013826-F354AAB9-8FE8-48EF-A271-623302FBF86C @default.
- Q91013826 P2093 Q91013826-F4C83FDE-083F-4408-82AF-3A6A9CB4BCBC @default.
- Q91013826 P304 Q91013826-29948519-3E3E-4196-A157-1EF31ED6306B @default.
- Q91013826 P31 Q91013826-F09F9CF1-B36F-40B6-8F1C-A539C017F824 @default.
- Q91013826 P356 Q91013826-C722ABAB-D745-4C54-93AF-2FD5A5CE08D4 @default.
- Q91013826 P433 Q91013826-8BF6389E-A83D-4258-834D-A16E53BF146F @default.
- Q91013826 P478 Q91013826-8EFE871C-91D9-4332-867B-1EB46B327579 @default.
- Q91013826 P50 Q91013826-441716B9-52B4-4657-9800-1AF26781F0C7 @default.
- Q91013826 P50 Q91013826-48083752-4279-45C4-AED2-B925CFF7A41E @default.
- Q91013826 P50 Q91013826-FBDB8743-B88F-4F6D-B273-5CACC3972F04 @default.
- Q91013826 P577 Q91013826-AED8C5C0-E8BC-40AB-A4ED-8B3CFDDBE206 @default.
- Q91013826 P698 Q91013826-0E7E89D6-9522-463C-AC55-6F1CD00F3BAB @default.
- Q91013826 P921 Q91013826-A03B5548-7976-4A2A-BD79-B708AAE80BA0 @default.
- Q91013826 P932 Q91013826-4016264F-4F75-4F7D-8883-A283A0F3FE7B @default.
- Q91013826 P356 S12955-019-1232-8 @default.
- Q91013826 P698 31729982 @default.
- Q91013826 P1433 Q15757755 @default.
- Q91013826 P1476 "Idelalisib addition has neutral to beneficial effects on quality of life in bendamustine/rituximab-treated patients: results of a phase 3, randomized, controlled trial." @default.
- Q91013826 P2093 "Alexander S Pristupa" @default.
- Q91013826 P2093 "Anna Schuh" @default.
- Q91013826 P2093 "Franck Morschhauser" @default.
- Q91013826 P2093 "Herbert Eradat" @default.